(Illustration by David Parkins) |
Statistical pitfalls of personalized medicine
“Causality is hard to study and difficult to prove,” says statistician Stephen Senn — and our failure to understand it is contributing to false hopes about the potential of personalized medicine. Senn calls out lazy language, arbitrary dichotomies, inappropriate yardsticks and ever-changing human physiology as some of the issues that stymie drugs in clinical trials.
Nature | 10 min read |
No comments:
Post a Comment